Medtronic announces strongly positive results for patients from procedural and design innovation of Evolut TAVR
Medtronic plc announced new data for the Evolut Transcatheter Aortic Valve Replacement System (TAVR) at PCR London Valves 2024. This new clinical evidence brings further insights to global… read more.
